Our business model is to cultivate lawyers who know all there is to know about intellectual property, whether it be special requirements under the America Invents Act (AIA), patenting chemical compositions and pharmaceuticals, current developments in software patenting, or combating “bad patents” in federal court litigation. Lawyers from our various practice groups enjoy sharing their views in our blogs. Please join our audience and help us enrich the discussion. We welcome your participation and insight.
John H. Ambrose, Jr. 2
Tyson B. Benson 2
Jewell N. Briggs 3
Elizabeth K. Brock 7
Matthew L. Cutler 183
Donald J. Daley 1
Darin W. Deaver 1
Gregory S. DeLassus 42
Nicholas S. Drysdale 3
Monte L. Falcoff 1
Glenn E. Forbis 10
Mark A. Frentrup, Ph.D. 2
Michael Gamble 1
Jason A. Heist 1
Hemant M. Keskar 4
Sung Pil Kim 1
Elisabeth A. Koral 1
Damian H. Kotsis, Ph.D. 2
Kisuk Lee 1
Robert J. Lenihan 1
Joshua A. Partington 2
Leanne M. Rakers 14
Douglas A. Robinson 11
Joel R. Samuels 2
Neal D. Sanborn 3
Jeffrey L. Snyder 1
Gregory A. Stobbs 9
David L. Suter 2
Michael L. Taylor 1
Jennifer R. Turchyn 2
Michael Varco 2
Joseph E. Walsh, Jr. 1
Andrew M. Waxman 2
Bryan K. Wheelock 252
Jennifer M. Woodside Wojtala 7
Paul E. Zarek, Ph.D. 2
